HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Transform Wealth LLC

Transform Wealth LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,278 shares of the company’s stock after purchasing an additional 2,847 shares during the period. Transform Wealth LLC’s holdings in HCA Healthcare were worth $7,587,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. FMR LLC boosted its holdings in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of HCA Healthcare by 11.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after purchasing an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after buying an additional 41,190 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of HCA Healthcare by 12.0% in the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after acquiring an additional 143,995 shares during the period. Finally, Darsana Capital Partners LP raised its stake in HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.4 %

NYSE HCA opened at $310.60 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $278.50 and a 52 week high of $417.14. The stock has a market cap of $78.68 billion, a P/E ratio of 13.95, a PEG ratio of 1.06 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company’s fifty day simple moving average is $315.74 and its 200-day simple moving average is $353.08.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insider Buying and Selling

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. Oppenheimer increased their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. TD Cowen dropped their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.